Skip to main content
. 2021 Mar 7;22(5):2690. doi: 10.3390/ijms22052690

Figure 3.

Figure 3

CD47-positive tumors contained significantly more SIRPA- or CD163-positive TAIs. (a) CD47-positive tumors contained significantly more SIRPA-positive TAIs (p = 0.044). (b) CD47-positive tumors tended to contain more CD68-positive TAIs (p = 0.080). (c) CD47-positive tumors contained significantly more CD163-positive TAIs (p < 0.0001). This is a figure. Schemes follow another format.